Navigation Links
Freedland Russo Announces $520 Million Settlement Against AstraZeneca
Date:4/27/2010

Freedland Russo is pleased that Eric Holder, U.S. Attorney General, announced the $520 million dollar settlement of a lawsuit filed against AstraZeneca (Civil Action #04-3479; US District Court, Eastern District of Pennsylvania).

Weston, Fla. (PRWEB) April 27, 2010 -- Freedland Russo is pleased that Eric Holder, U.S. Attorney General, announced the $520 million dollar settlement of a lawsuit filed against AstraZeneca (Civil Action #04-3479; US District Court, Eastern District of Pennsylvania). The settlement announced today in Philadelphia indicates marketing practices for Seroquel included promotion of the drug by physicians participating in clinical studies and drug sales representatives encouraging doctors to prescribe for unapproved uses.

Only fifteen months since Eli Lilly agreed to pay $1.4 Billion to resolve claims relating to Zyprexa, the law firm of Freedland Russo has again proven to be tireless advocates in matters relating to the Pharmaceutical Industry (Civil Action #03943). The AstraZeneca complaint was filed in 2004 on behalf of a whistleblower by Freedland Russo and their co-counsel, Philadelphia attorney Stephen A. Sheller, Esq.

Seroquel is among the top-selling drugs in the world with 2009 sales of $4.9 billion; 15% of AstraZeneca’s $33.2 billion in revenue is for schizophrenia and specific types of bipolar mania. AstraZeneca was charged with promoting Seroquel to physicians for use “off-label” in children and the elderly. Doctors are allowed to prescribe drugs for unapproved uses but FDA rules state that drug manufacturers may only promote their products for approved conditions and age groups.

“This is just another step in getting the attention of the entire pharmaceutical industry,” Partner Michael Freedland said. Attorney Daniel Harwin agrees that more action should be taken against pharmaceutical companies for illegally marketing their products. “This is a industry-wide problem and not limited to a few isolated companies. We have to keep pressing onward because the health, safety and well being of the public hangs in the balance,” Harwin said.

Whistleblowers are protected by the federal False Claims Act, where employees aware of their company knowingly defrauding the government may sue without threat of being fired, harassed, demoted, or discriminated against for cooperating in an investigation of their employer.

“Once again, a single brave person came to the forefront and held a big pharmaceutical company accountable,” said Freedland. “With each case that we pursue, we learn more about the internal workings of these companies and just how far they are willing to push the limits.”

Partner Anthony Russo added, “We are also thrilled that the majority of this settlement will go back to whom it belongs, the taxpayers and the states.” In that regard, the firm lauded the team in the U.S. Attorney’s office for their investigation, including Chief of the Civil Division Virginia Gibson and Assistant U.S. Attorney Colin Cherico. “As they did with Eli Lilly, the U.S. Attorney’s office in Philadelphia proved their commitment to recouping hundreds of millions for the government and its citizen taxpayers,” said Russo.

About Freedland Russo:
Freedland Russo is a law firm committed to assisting and fighting for consumers in the United States who have suffered social injustices at the hands of individuals, large corporations, and insurance companies. The firm lawyers are renowned for handling complex cases involving matters of medical malpractice, pharmaceutical liability, automobile liability, wrongful death, and whistleblower cases. Freedland Russo is based in Weston, Florida. For more information log on to www.westonlawyers.com or call 888.254.7066

Bob Sands
Sands Communications, Inc.
Direct: (954) 260-3826

###

Read the full story at http://www.prweb.com/releases/Freedland_Russo/AstraZeneca_settlement/prweb3934034.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. National Allergy Supply, The Allergy Products Company Recommended By More Than 9,500 Doctors Nationwide, Announces 100% Unconditional Satisfaction Guarantee
2. CureTogether Announces Online Autism Treatment Study
3. MetaGeek Announces Chanalyzer Pro Spectrum Analysis Software for Wi- Spy, Adds Device Classification, Device Finder and Automated Reports
4. Instaflex Announces Partnership with GNC, the Nation's Leading Vitamin and Supplement Retailer
5. Sundial Creations Announces the Debut of SheaMoisture Organic Hair Care Exclusively at Target
6. CA Commercial Realty Partners Announces “Free Lease Review for local Businesses"
7. International Desalination Association Announces Members of Environmental Task Force and Dates for Environmental Symposium
8. The American Society for Aesthetic Plastic Surgery (ASAPS) Announces the 2010 Journalistic Achievement Award Winners
9. 1Dental.com Announces Affordable Dental Plan Sponsorship Video by Sweet Tea Films' Tavin Dillard
10. Reflex Stock Limited Announces Two New Ways to Buy Stock Images and Stock Photos
11. Microwize Technology Announces Partnership with ScanMyCharts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... , ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 ... image mannequin art competition. Selected from 15 submissions from around the nation, the top ... 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This year, ...
(Date:2/24/2017)... ... 24, 2017 , ... Castle Farms, the celebrated Northern ... with the winning couple announced on Feb. 14, 2017, on Facebook. The free ... vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring and ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, which is ... in Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) ... website, weekly e-newsletter and quarterly publication, will be conducting interviews with patients and ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information ... National Institute for Health and Care Excellence (NICE) framework. The agreement ... Health Service (NHS) to search, order and purchase medical and healthcare-related content through ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... today that it will soon begin franchising throughout the U.S. starting this spring. ... help bring the practice of meditation mainstream. Current Meditation will be the first ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... USD 330.6 million by 2021 from USD 275.9 ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... industries, increasing spending on pharmaceutical R&D, and growth ... factors driving the market growth for particle counters. ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
(Date:2/23/2017)... Calif., Feb. 23, 2017 Nevro Corp. (NYSE: NVRO), ... solutions for the treatment of chronic pain, today reported financial ... 31, 2016. 2016 Accomplishment & Highlights: ... year 2016, an increase of 228% as reported, over the ... 2016, an increase of 612% over the prior year ...
Breaking Medicine Technology: